Economic evaluation of aromatase inhibitors for the treatment of breast cancer
Economic evaluation of aromatase inhibitors for the treatment of breast cancer
About this item
Full title
Author / Creator
Publisher
London: Informa Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
London: Informa Healthcare
Subjects
More information
Scope and Contents
Contents
Breast cancer affects 1 million women a year. Hormonal therapy has been a mainstay of treatment for women with hormone-sensitive breast cancer. The newer class of aromatase inhibitors has challenged the use of the previous standard agent, tamoxifen, in the treatment and prevention of breast cancer. This article will provide a thorough review of the...
Alternative Titles
Full title
Economic evaluation of aromatase inhibitors for the treatment of breast cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_870518979
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_870518979
Other Identifiers
ISSN
1473-7167
E-ISSN
1744-8379
DOI
10.1586/14737167.3.6.773
